Saab AB/ SE0021921269 /
2024-08-05 8:21:53 PM | Chg. -1.5000 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
21.5000USD | -6.52% | 3,000 Turnover: 64,728 |
-Bid Size: - | -Ask Size: - | 11.72 bill.USD | - | - |
GlobeNewswire
06-03
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational G...
Newsfile Corp
04-11
Tor Holding and ELIE SAAB Announce Partnership for Dual Real Estate Debut in Turkey
GlobeNewswire
04-04
Schneider Electric announces global winners of second edition of its Sustainability Impact Awards
GlobeNewswire
04-03
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
GlobeNewswire
2023-12-19
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
2023-11-29
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
2023-11-13
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
2023-11-03
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...